FDA-Drug2026-03-25Class IIPROCESSING DEFECT
Apotex brimonidine/timolol eye drops recalled for sterility concerns
OTHERNationwide distribution
Stop using Apotex brimonidine/timolol eye drops
Apotex Corp. is recalling specific lots of brimonidine tartrate/timolol maleate eye drops because the manufacturer cannot confirm the product was sterilized properly. The affected lots are VJ8599 (expires 09/30/2026) and VL1668 (expires 01/31/2027). No infections or injuries have been reported so far.
- Check your eye drop bottle for lot number VJ8599 or VL1668
- Do not use the product if it matches either lot number
- Contact your pharmacy or doctor for a replacement prescription
- Call Apotex Corp. at the number on your bottle if you have questions
Hazard
Lack of Assurance of Sterility
Sold states
U.S. Nationwide
Affected count
107,136 vials
Manufactured in
2400 N Commerce Pkwy Ste 400, N/A, Weston, FL, United States
Products
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0407-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief